FTVSX
Price
$32.58
Change
-$0.13 (-0.40%)
Updated
Dec 2 closing price
Net Assets
354.22M
JVMRX
Price
$30.08
Change
-$0.13 (-0.43%)
Updated
Dec 2 closing price
Net Assets
24.39B
Interact to see
Advertisement

FTVSX vs JVMRX

Header iconFTVSX vs JVMRX Comparison
Open Charts FTVSX vs JVMRXBanner chart's image
FullerThaler Behav Md-Cp Val Instl
Price$32.58
Change-$0.13 (-0.40%)
VolumeN/A
Net Assets354.22M
JHancock Disciplined Value Mid Cap R6
Price$30.08
Change-$0.13 (-0.43%)
VolumeN/A
Net Assets24.39B
FTVSX vs JVMRX Comparison Chart in %
View a ticker or compare two or three
VS
FTVSX vs. JVMRX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTVSX is a Buy and JVMRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMRX has more cash in the bank: 24.4B vs. FTVSX (354M). FTVSX pays higher dividends than JVMRX: FTVSX (1.48) vs JVMRX (0.83). FTVSX was incepted earlier than JVMRX: FTVSX (8 years) vs JVMRX (14 years). FTVSX (1.03) is less costly to investors than JVMRX (0.75). JVMRX is a more actively managed with annual turnover of: 49.00 vs. FTVSX (33.00). FTVSX has a lower initial minimum investment than JVMRX: FTVSX (100000) vs JVMRX (1000000). JVMRX annual gain was more profitable for investors over the last year : -5.80 vs. FTVSX (-9.16). FTVSX return over 5 years is better than : 48.22 vs. JVMRX (33.99).
FTVSXJVMRXFTVSX / JVMRX
Total Expense Ratio0.850.74115%
Annual Report Gross Expense Ratio1.030.75137%
Fund Existence8 years14 years-
Gain YTD-3.88712.138-32%
Front LoadN/AN/A-
Min. Initial Investment100000100000010%
Min. Initial Investment IRAN/AN/A-
Net Assets354M24.4B1%
Annual Yield % from dividends1.480.83178%
Returns for 1 year-9.16-5.80158%
Returns for 3 years12.0214.7382%
Returns for 5 years48.2233.99142%
Returns for 10 yearsN/A51.15-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAOSX56.36N/A
N/A
Janus Henderson Overseas T
RYOIX84.29N/A
N/A
Rydex Biotechnology Inv
RMQAX693.55N/A
N/A
Rydex Monthly Rbl NASDAQ-100® 2x Strt A
GSEPX75.53N/A
N/A
Goldman Sachs US Equity Insights P
FMMMX48.27N/A
N/A
American Funds AMCAP 529-F-2